ARK Genomic Revolution ETF (ARKG) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
ARK Genomic Revolution ETF (ARKG) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $1.02B, listed on CBOE, carrying a beta of 2.35 to the broader market. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution. public since 2014-10-31.
Snapshot as of May 15, 2026.
- Spot Price
- $28.20
- ATM IV
- 44.0%
- IV Skew 25Δ
- 0.036
- IV Rank
- 19.4%
- IV Percentile
- 40.5%
- Term Structure Slope
- -0.007
As of May 15, 2026, ARK Genomic Revolution ETF (ARKG) at-the-money implied volatility is 44.0%. IV rank is 19.4% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 40.5%. The 25-delta skew is +0.036: calls carry premium over puts, indicating upside speculation or squeeze risk. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
ARKG Strategy Selection at Current Volatility Levels
For ARK Genomic Revolution ETF options at 44.0% ATM IV, low IV rank (19.4%) favors premium-buying or long-vol structures: long calls or puts, debit spreads, calendar spreads, long straddles. The risk: low-rank regimes can persist for months while time decay eats premium-buyers alive. The 25-delta skew tilts to calls, so call-credit spreads or covered-call writes harvest more premium than put-credit spreads of the same width. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked ARKG volatility skew questions
- What is the current ARKG ATM implied volatility?
- As of May 15, 2026, ARK Genomic Revolution ETF (ARKG) at-the-money implied volatility is 44.0%. IV rank is 19.4% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is ARKG IV high or low historically?
- IV is subdued relative to its 1-year history, conditions that typically favor premium-buying strategies (long calls, long puts, debit spreads, calendar spreads).
- What does ARKG volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. ARK Genomic Revolution ETF shows upside-skewed pricing: 25-delta calls trade richer than 25-delta puts, often reflecting upside speculation or squeeze risk. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.